Qingjian He
Huzhou, 313000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Cardiovascular Toxicity of BTKi in Chronic B-Cell Malignancies.
Journal: Reviews in cardiovascular medicine
Published: October 27, 2025
Investigation into the sensitivity of adipocytes mediated by the major vault protein (MVP) to chemotherapy for triple-negative breast cancer.
Journal: Translational cancer research
Published: June 03, 2025
Investigation of the mechanism of hypertension caused by BTKi in the treatment of hematologic diseases.
Journal: Frontiers in pharmacology
Published: February 28, 2025
Clinical study of the diagnosis of thyroid tumours using Raman spectroscopy.
Journal: Brazilian journal of otorhinolaryngology
Published: September 03, 2024
Endothelin receptor antagonists (ERAs) can potentially be used as therapeutic drugs to reduce hypertension caused by small molecule tyrosine kinase inhibitors (TKIs).
Journal: Frontiers in pharmacology
Published: July 12, 2024
Microvascular rarefaction caused by the NOTCH signaling pathway is a key cause of TKI-apatinib-induced hypertension and cardiac damage.
Journal: Frontiers in pharmacology
Published: November 30, 2023
Apatinib Through Activating the RhoA/ROCK Signaling Pathway to Cause Dysfunction of Vascular Smooth Muscle Cells.
Journal: Applied biochemistry and biotechnology
Published: May 27, 2022
Research on the Mechanism and Prevention of Hypertension Caused by Apatinib Through the RhoA/ROCK Signaling Pathway in a Mouse Model of Gastric Cancer.
Journal: Frontiers in cardiovascular medicine
Published: February 11, 2022
A narrative review on the interaction between genes and the treatment of hypertension and breast cancer.
Journal: Annals of translational medicine
Published: June 24, 2021
A New Embedded Key-Value Store for NVM Device Simulator.
Journal: Micromachines
Published: October 29, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026